Printer Friendly
The Free Library
19,607,059 articles and books
Member login
User name  
Password 
 
Join us Forgot password?

CytoDyn Adds Prominent AIDS Clinician and Immunologist Dr. Robert H. Keller to Its Scientific Advisory Board.


SANTA FE, N.M. -- Prominent clinician and immunologist Robert H. Keller, M.D., M.C., FACP FACP Fellow of the American College of Physicians.

FACP
abbr.
1. Fellow of the American College of Physicians

2. Fellow of the American College of Prosthodontists
, AAHIVS has joined the Scientific Advisory Board of CytoDyn, Inc. (OTCBB OTCBB

See OTC Bulletin Board (OTCBB).
:CYDY). Dr. Keller has been at the bedside of patients with HIV/AIDS HIV/AIDS Human Immunodeficiency Virus/Acquired Immune Deficiency Syndrome  since the beginning of the AIDS pandemic. His extensive experience in managing the disease gives Dr. Keller the important clinical insights that can only be gained through the practice of clinical medicine.

Academically, Dr. Keller is a pioneer in the field of immunology. He received his M.D. with honors in 1970 from Temple University in Philadelphia, Pa. From 1974-1976 he was a Fellow and Senior Fellow in the Department of Immunology at the Mayo Clinic in Rochester, N.Y., earning his Master of Science in Immunology from the same institution in 1976. During 1974-1976, he became Fellow and Senior Research Fellow in Immunology at the Mayo Clinic Foundation. In 1976, he was appointed Assistant Professor in Medicine at the University of Minnesota (body, education) University of Minnesota - The home of Gopher.

http://umn.edu/.

Address: Minneapolis, Minnesota, USA.
.

From 1977-1980, Dr. Keller was an Assistant Professor in the Hematology/Oncology section of the Department of Medicine at the Medical College of Wisconsin in Milwaukee, Wis. From 1979-1982, he was also a Clinical Associate Professor of Hematology, Immunology and Flow Cytometry at the Department of Health Services Department of Health Services may refer to:
  • Los Angeles County Department of Health Services
  • California Department of Health Services a California state agency
 at the University of Wisconsin in Milwaukee, and from 1980-1982 was Director of Immunology at the Midwest Children's Cancer Center in the same city.

In 1986, Dr. Keller relocated to Hialeah, Fla., to serve as Associate Director of Research and Development at Coulter Immunology, a leading supplier of flow cytometers and reagents. Subsequently, he established his medical practice in Florida, and since 1998 has served as a Voluntary Adjunct Professor at the Miller School of Medicine, University of Miami This article is about the university in Coral Gables, Florida. For the university in Oxford, Ohio, see Miami University.

The University of Miami (also known as Miami of Florida,[2] UM,[3] or just The U
, in Miami, Fla.

Dr. Keller is the author of over 100 peer review research and clinical articles. He has served on the Editorial Boards of Diagnostic Immunology (1986-1990), Journal of Leukocyte leukocyte (l`kəsīt'): see blood.
leukocyte
 or white blood cell or white corpuscle
 Biology (1984-1986) and Interventions in Aging (2005- ). His many honors include the Humanitarian of the Year Award from the National Hemophilia Federation, and election to the Board of Governors of the Florida Chapter of the American Academy of HIV HIV (Human Immunodeficiency Virus), either of two closely related retroviruses that invade T-helper lymphocytes and are responsible for AIDS. There are two types of HIV: HIV-1 and HIV-2. HIV-1 is responsible for the vast majority of AIDS in the United States.  Medicine. Dr. Keller was also voted one of America's top physicians in internal medicine, immunology and hematology by the Consumer's Research Council of America.

"We are proud and honored to have Dr. Keller on our team, especially since his experience and credentials coincide with the focus of our pipeline," said Allen D. Allen, CEO (1) (Chief Executive Officer) The highest individual in command of an organization. Typically the president of the company, the CEO reports to the Chairman of the Board.  of CytoDyn.

Disclaimer

This news release is limited to historical facts obtained from Dr. Keller and relied on in good faith by the Company. In the opinion of the Company, this news release makes no forward-looking statements. There is no assurance that the participation of Dr. Keller in the Company's activities will result in a favorable outcome for the Company.
COPYRIGHT 2006 Business Wire
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2006, Gale Group. All rights reserved. Gale Group is a Thomson Corporation Company.

 Reader Opinion

Title:

Comment:



 

Article Details
Printer friendly Cite/link Email Feedback
Publication:Business Wire
Date:Sep 20, 2006
Words:474
Previous Article:Wataire Industries Files US Patent Application to Control Biofilm in Drinking Water.
Next Article:Juniper Networks Earns 'Rising Star' Award From Information Technology Distribution Industry; Honor Recognizes Technology Industry's Fastest-Growing...
Topics:



Related Articles
NIH director faces congressional scrutiny.
Large-scale AIDS vaccine test delayed.
AIDS Vaccine Tests Well in Monkeys.
AIDS PANEL CALLS FOR OVERHAUL OF FEDERAL RESEARCH.
PUTTING HIS TRUST IN SALK\Testing to begin on AIDS drug.
NOBEL AWARDED TO 2 DOCTORS FOR IMMUNE SYSTEM RESEARCH.
Malone joins G-A board.
CytoDyn Welcomes Dr. Trevor Hawkins to Its Scientific Advisory Board.
CytoDyn Invited to Present at XVI World AIDS Conference.

Terms of use | Copyright © 2012 Farlex, Inc. | Feedback | For webmasters | Submit articles